Publications
Publications
In Process
2012
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000 and earlier
Zeliadt SB, Buist DS, Reid RJ, Grossman DC, Ma J, Etzioni R. Biopsy follow-up of Prostate Specific Antigen Tests. American Journal of Preventative Medicine. 2012 Jan: 42(1): 37-43. Abstract
Gulati R, Mariotto AB, Chen S, Gore JL, Etzioni R. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. Journal of Clinical Epidemiology. 2011 Dec: 64(12): 1412-7. Abstract
Zeliadt SB, Buist D, Reid R, Grossman D, Chen S, Etzioni R. PS2-43: Prostate Specific Antigen Tests in Clinical Practice over the Past Decade: Is the Threashold for Recommending Biopsy Dropping? Clinical Medicine & Research. 2011 Nov: 9(3-4): 146-7.
Zeliadt SB, Hoffman RM, Etzioni R, Gore JL, Kessler LG, Lin, DW. Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices. Journal of the National Cancer Institute. 2011 Mar 16: 103(6): 520-3. PMCID: PMC3091266. Abstract
Gulati R, Wever E, Tsodikov A, Penson DF, Inoue LYT, Katcher J, Lee SY, Heijnsdijk E, Draisma G, de Koning H, Etzioni R. What if I don’t treat my PSA-detected prostate cancer? Results from three natural history models. Cancer Epidemiology, Biomarkers and Prevention. 2011 May: 20(5): 740-50. PMCID: PMC3091266. Abstract
Ramsey SD, Etzioni R. Case-control studies of cancer surveillance procedures. Journal of Clinical Epidemiology. 2011 Jan;64(1):44. Abstract
Gulati R, Inoue L, Katcher J, Hazelton W, Etzioni R. Calibrating disease progression models using population data: A critical precursor to policy development in cancer control. Biostatistics. 2010 Oct;11(4):707-19. Epub 2010 Jun 7. PMCID: PMC2950791 Abstract/ Full Text
Yu EY, Gulati R, Telesca D, Jiang P, Tam S, Russell KJ, Nelson PS, Etzioni RD, Higano CS. Duration of first off treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation. J Clin Oncol. Jun 1;28(16):2668-73. Epub 2010 Apr 26. PMCID: PMC2881848. Abstract/ Full Text
Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw. 2010 Feb;8(2):240-62. Abstract
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, Brooks DD, Dash C, Guessous I, Andrews K, DeSantis C, Smith RA; American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. Epub 2010 Mar 3. Abstract / Full Text
Zeliadt SB, Hoffman RM, Etzioni R, Ginger VA, Lin DW. What Happens After an Elevated PSA Test: The Experience of 13,591 Veterans. Journal of General Internal Medicine. 2010 Nov;25(11):1205-10. Epub 2010 Aug 10. PMCID: PMC2947635. Abstract / Full Text
Morrissey C, Gallis B, Solazzi JW, Kim BJ, Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL, Sasaki T. Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs. 2010 Apr;21(4):423-32. PMCID: PMC2953769. Abstract
Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, Boyer B, Mohatt GV. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am J Clin Nutr. 2010 Mar;91(3):777-85. Epub 2010 Jan 20. PMCID: PMC2824158. Abstract
Morrissey C, Lai JS, Brown LG, Wang YC, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells. Prostate. 2010 Mar 1;70(4):412-24. PMCID: PMC2929015. Abstract
Shaw PA, Pepe MS, Todd A, Etzioni R. Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test. Statistics in Biopharmaceutical Research. Feb 2009, 1(1): 18-25. PMC2802069. Abstract / Full Text
Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiology Biomarkers and Prevention. 2009 Mar;18(3):808-15. Epub 2009 Mar 3. PMC2750884. Abstract / Full Text
Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Feuer E, de Koning H. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. Journal of the National Cancer Institute. 2009 Mar 18;101(6):374-83. Epub 2009 Mar 10. PMC2720697. Abstract / Full Text
Telesca D, Inoue LY, Neira M, Etzioni R, Gleave M, Nelson C. Differential expression and network inferences through functional data modeling. Biometrics. 2009 Sep;65(3):793-804. Epub 2008 Nov 13. Abstract / Full Text
Benzo R, Farrell MH, Chang CC, Martinez FJ, Kaplan R, Reilly J, Criner G, Wise R, Make B, Luketich J, Fishman AP, Sciurba FC; NETT Research Group. Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med. 2009 Aug 1;180(3):239-46. Epub 2009 May 29. Abstract / Full Text
Etzioni R, Gulati R, Falcon S, Penson DF. Impact of PSA screening on the incidence of advanced stage prostate cancer in the US: A surveillance modeling approach. Medical Decision Making. 2008 Mar 4;28:323-331. Abstract / Full Text
Inoue LYT, Etzioni R, Morrell C, Müller P. Modeling Disease Progression with Longitudinal Markers. Journal of the American Statistical Association. 2008 Mar;103(481):259-270. Abstract
Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, diTommaso D, Karnofski K, Gulati R, Penson DFG, Feuer EJ. Quantifying the Role of PSA Screening in the US Prostate Cancer Mortality Decline. Cancer Causes and Control. 2008 Mar;19(2):175-81. Abstract / Full Text
Telesca D, Gulati R, Etzioni R. Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends. Biometrics. 2008 Mar;64(1):10-9.Abstract / Full Text
Etzioni R. Statistical Issues in the Evaluation of Screening and Early Detection Modalities. Urologic Oncology 2008 May-Jun; 26(3): 308-15. Abstract / Full TextEtzioni R, Ankerst DP, Weiss NS, Inoue LYT, Thompson IM. Is PSA Velocity Useful in Early Detection of Prostate Cancer? A Critical Appraisal of the Evidence. Journal of the National Cancer Institute. 2007 Oct 17; 99:1510-1515.Abstract / Full Text
Inoue LYT, Etzioni R, Nelson CC, Gleave M, Neira M. Cluster-based network models for time-course gene expression data. Biostatistics. 2007 Jul; 8(3):507-525. Abstract / Full Text
Zeliadt SB, Etzioni RD, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Medical Care. 2007 Feb; 45(2):154-159.Abstract / Full Text
Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing prostate-specific antigen (PSA) testing patterns among black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer. 2007 Mar 19;109(9):1877-1886. Abstract / Full Text
Ramsey SD, Howlader N, Etzioni R, Brown M, Warren J, Newcomb P. Surveillance Endoscopy does not Improve Survival for Patients with Local and Regional Stage Colorectal Cancer. Cancer. 2007 Jun 1;109(11):2222-2228. Abstract / Full Text
Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP 3rd, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT; National Comprehensive Cancer Network. Prostate cancer early detection. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2007 Aug;5(7):714-36. DeConde R, Hawley SJ, Falcon S, Clegg N, Knudsen B, Etzioni R. Combining Results of microarray experiments: A Rank Aggregation Approach. Statistical Applications in Genetics and Molecular Biology.2006 June. 5(1): Article 15. Abstract / Full Text
Zeliadt SB, Potosky AL, Penson DF, Etzioni R. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. International Journal of Radiation Oncology, Biology, Physics 2006 Oct 1;66(2):395-402. Abstract / Full Text
Pinsky P, Etzioni R, Howlader, N, Goodman P, Thompson, I. Modeling the Effect of a Preventive Intervention on the Natural History of Prostate Cancer: Application to the Prostate Cancer Prevention Trial. International Journal of Biostatistics. 2006 2(1): Article 12. Available at: http://www.bepress.com/ijb/vol2/iss1/12.Abstract / Full Text
Zeliadt SB, Etzioni R, Penson DF, Thompson IM, Ramsey SD. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. American Journal of Medicine. 2005 August; 118(8): 850-7. Abstract / Full Text
Zeliadt SB, Etzioni R, Kristal AR. Estimated impact of the prostate cancer prevention trial on population mortality. Cancer. 2005 Oct 1; 104(7):1556-1557. Abstract / Full Text
Moore S, Knudsen B, True L, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I, Nelson PS. Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma. International Journal of Cancer. 2005 April 20; 114(4): 563-571. Abstract / Full Text
Friedrichsen DM, Hawley S, Shu J, Humphrey M, Sabacan L, Iwasaki L, Etzioni R, Ostrander EA, Stanford JL. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate. 2005 Sep 15; 65(1):44-51. Abstract / Full Text
Etzioni R, Falcon S, Gann PH, Kooperberg C, Penson DF, Stampfer MJ. PSA and free PSA in the early detection of prostate cancer: do combination tests improve detection? Cancer Epidemiology, Biomarkers, and Prevention. 2004 Oct 13(10):1640-5. Abstract / Full Text
Etzioni R, Thomas DB. [Invited Editorial] Modeling the effect of screening for cervical cancer on the population. Lancet. 2004 Jul 17;364 (9430):224-6. Abstract / Full Text
Shaw PA, Etzioni R, Zeliadt SB, Mariotto M, Karnofski K, Penson DF, Weiss NS, Feuer EJ. An Ecologic Study of PSA Screening and Prostate Cancer Mortality in Nine Geographic Areas of the US. American Journal of Epidemiology. 2004 Dec 1;160(11):1059-69. Abstract / Full Text
Feuer EJ, Etzioni R, Cronin K, Mariotto A. The Use of Modeling to Understand the Impact of Screening on US Mortality: Examples from Mammography and PSA Testing. Statistical Methods in Medical Research. 2004 Dec; 13(6) 421-42. Abstract
Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004 Dec; 64(6):1171-6. Abstract / Full Text
Weiss NS, Dhillon P, Etzioni R. Case-control studies of the efficacy of cancer screening: Overcoming bias due to non-random patterns of screening in the source population. Epidemiology. 2004 Jul 15(4): 409-413. Abstract / Full Text
Inoue L, Etzioni R, Slate EH, Morrell C. Combining longitudinal studies of PSA. Biostatistics. 2004 Jul;5(3): 483-500. Abstract / Full Text
Ramsey SD, Howlader N, Etzioni R, Donato B. Chemotherapy Use, Outcomes, and Costs for Older Persons with Advanced Non-Small Cell Lung Cancer: Evidence from SEER-Medicare. Journal of Clinical Oncology. 2004 Dec 15; 22(24): 4971-8. Abstract / Full Text
Ramsey SD, Mandelson MT, Etzioni R, Harrison R, Smith R, Taplin S. Can administrative data identify incident cases of colorectal cancer? A comparison of health plans. Health Services and Outcomes Research Methodology. 2004; 5: 27-37. Abstract
Lai JS, Brown LG, True LD, Hawley SJ, Etzioni R, Higano CS, Ho SM, Vessella RL, Corey E. Metastases of Prostate Cancer Express Estrogen Receptor-Beta. Urology. 2004 Oct 64:814-820.Abstract / Full Text
Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L. The case for early detection. Nature Reviews Cancer. 2003 Apr;3:243-252. Abstract / Full Text
Etzioni R, Kooperberg C, Pepe M, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics. 2003 Oct;4(4):523-538. Abstract / Full Text
Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis. Cancer 2003 Aug 1;98(3):496-503. Abstract / Full Text
Lamharzi N, Johnson MM, Goodman G, Etzioni R, Weiss NS, Dightman DA, Barnett M, DiTommaso D, Chen C. Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer. International Journal of Cancer. 2003 Jul 1;105(4):480-483. Abstract / Full Text
Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE. Endogenous Sex Hormones and Prostate Cancer Risk: A Case-Control Study Nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiology, Biomarkers and Prevention. 2003 Dec 1;12(12):1410-1416. Abstract / Full Text
Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE; National Emphysema Treatment Trial Research Group. Cost-effectiveness of lung-volume-reduction surgery for patients with severe emphysema. New England Journal of Medicine. 2003 May 22;348(21):2092-2102. Abstract / Full Text
Ramsey SD, Mandelson MT, Berry KM, Etzioni RD, Harrison R. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology. 2003;125(6):1645-1650. Abstract / Full Text
Etzioni R, Riley GF, Ramsey SD, Brown M. Measuring costs: administrative claims data, clinical trials, and beyond. Medical Care 2002 Jun;40(6 Suppl):III63-III72. Review. Abstract
Etzioni R, Berry KM, Legler J, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of Medicare claims from 1991-1998. Urology 2002 Feb;59(2):251-255. Abstract / Full Text
Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 2002 Oct;11(10 Pt 1):1033-1040. Abstract / Full Text
Weiss NS, Etzioni R. Estimating the influence of rescreening interval on the benefits associated with cancer screening: approaches and limitations. Epidemiology 2002 Nov;13(6):713-717. Review. Abstract / Full Text
Kessler LG, Andersen MR, Etzioni R. Much ado about mammography variability. Journal of the National Cancer Institute 2002 Sep 18:94(18):1346-1347. Abstract / Full Text
Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical Care 2002 Aug;40(8 Suppl):IV-104-IV-17. Abstract / Full Text
Ramsey SD, Berry K, Etzioni R. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. American Journal of Gastroenterology 2002 Feb;97(2):440-445. Abstract / Full Text
Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study. Health Economics 2001 Apr;10(3):245-256. Abstract
Ellis WJ, Etzioni R, Vessella RL, Hu C, Goodman GE. Serial prostate specific antigen, free-to-total prostate specific antigen ratio, and complexed prostate specific antigen for the diagnosis of prostate cancer. Journal of Urology 2001 Jul;166(1):93-98; discussion 98-99. Abstract
Sullivan Pepe M, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. Journal of the National Cancer Institute 2001 Jul 18:93(14):1054-1061. Review. Abstract / Full Text
Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Annals of Internal Medicine 2001 Oct 16:135(8 Pt 1):577-588. Abstract / Full Text
Andersen MR, Yasui Y, Meischke H, Kuniyuki A, Etzioni R, Urban N. The effectiveness of mammography promotion by volunteers in rural communities. American Journal of Preventive Medicine 2000 Apr;18(3):199-207.Abstract / Full Text
Ramsey SD, McIntosh M, Etzioni R and Urban N. Simulation modeling of outcomes and cost effectiveness. Hematology/Oncology Clinics of North America 2000 Aug;14:925-938. Review. Abstract
Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, Urban N. Quality of life in survivors of colorectal carcinoma. Cancer 2000 Mar 15;88(6):1294-1303. Abstract / Full Text
Etzioni R, Cha R, Cowen M. Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies. Journal of Urology 1999 Sep;162 (3 Pt 1):741-748. Abstract / Full Text
Etzioni RD, Feuer EJ, Sullivan SD, Lin D, Hu C, Ramsey SD. On the use of survival analysis techniques to estimate medical care costs. Journal of Health Economics 1999 Jun;18:365-380. Abstract / Full Text
Etzioni R, Pepe M, Longton G, Hu C, Goodman G. Incorporating the time dimension in receiver operating characteristic curves: a case study of prostate cancer. Medical Decision Making 1999 Jul-Sep;19(3):242-251. Abstract
Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer-part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. Journal of the National Cancer Institute 1999 Jun 16;91(12):1033-1039. Abstract / Full Text
Feinstein LC, Seidel K, Jocum J, Bowden RA, Anasetti C, Deeg HJ, Flowers ME, Kansu E, Martin PJ, Nash RA, Storek J, Etzioni R, Appelbaum FR, Hansen JA, Storb R, Sullivan KM. Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. Biology of Blood and Marrow Transplantation 1999:5(6):369-378. Abstract / Full Text
Brown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Medical Care 1999 Dec;37(12):1249-1259. Abstract / Full Text
Andersen MR, Urban N, Etzioni R. Community attitudes and mammography use: does it really matter what other people think? Women and Health 1999;29(3):83-95. Abstract
